Paper1978425
Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals.
Mytilineos J and 2 others. Transplantation, 1990. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals. Papers, record 1978425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1978425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HLA-DR Antigens | Major topic |
| Histocompatibility Testing | Major topic |
| Polymorphism, Restriction Fragment Length | Major topic |
| Alleles | |
| Humans | |
| Serotyping | |
| Transplantation Immunology |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23053058 | Search for schizophrenia susceptibility variants at the HLA-DRB1 locus among a British population. | Immunogenetics | 2013 | https://conductscience.org/library/papers/23053058 | PubMed |
| 8871162 | Central corneolimbal transplantation under systemic ciclosporin A cover for severe limbal stem cell insufficiency. | Graefes Arch Clin Exp Ophthalmol | 1996 | https://conductscience.org/library/papers/8871162 | PubMed |
| 8871161 | Systemic ciclosporin A in high-risk keratoplasties. | Graefes Arch Clin Exp Ophthalmol | 1996 | https://conductscience.org/library/papers/8871161 | PubMed |
| 8529907 | DNA-based HLA class II postmortem typing: evaluation of different techniques for prospective corneal allografting. | Graefes Arch Clin Exp Ophthalmol | 1995 | https://conductscience.org/library/papers/8529907 | PubMed |
| 8529095 | Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia. | Mol Med | 1995 | https://conductscience.org/library/papers/8529095 | PubMed |
| 8089216 | HLA-DR typing for kidney transplants: advantage of polymerase chain reaction with sequence specific primers in a routine hospital laboratory. | J Clin Pathol | 1994 | https://conductscience.org/library/papers/8089216 | PubMed |
| 7587773 | Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7587773 | PubMed |
| 1753685 | Perspectives in transplantation immunology 1991. | Klin Wochenschr | 1991 | https://conductscience.org/library/papers/1753685 | PubMed |
| 1450630 | Current status of HLA matching in renal transplantation. The Collaborative Transplant Study. | Clin Investig | 1992 | https://conductscience.org/library/papers/1450630 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1978425
GET https://conductscience.org/api/papers/v1/1978425/authors